Loading company…
Pleno develops biological detection and diagnostic solutions for clinical testing and research.
Founded in 2017 and based in California, Pleno provides biological target detection and diagnostics for clinical testing and biomedical research. Its Hypercoding technology analyzes DNA, RNA, methylation and proteomic content for applications including screening, diagnostics and prognostics. In December 2024, it raised USD 25 million in Series B funding from Deerfield Management, Foresite Capital, Medical Excellence Capital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in